Abstract
Generating genetically modified animal models that precisely recapitulate disease characteristics forms an integral and indispensable tool to understanding disease pathophysiology. Recently, important advances in genome editing technologies have enabled us to efficiently create sophisticated animal models in short periods of time. Base editing is a modified CRISPR/Cas system that induces base substitution at targeted genomic regions. Here I describe a basic protocol to introduce disease-relevant pathogenic mutations into mice utilizing two representative base editing tools, Base Editor and Target-AID.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Sasaguri H, Nilsson P, Hashimoto S, Nagata K, Saito T, De Strooper B et al (2017) APP mouse models for Alzheimer's disease preclinical studies. EMBO J 36:2473–2487
Saito T, Matsuba Y, Yamazaki N, Hashimoto S, Saido TC (2016) Calpain activation in Alzheimer’s model mice is an artifact of APP and Presenilin overexpression. J Neurosci 36:9933–9936
Gamache J, Benzow K, Forster C, Kemper L, Hlynialuk C, Furrow E et al (2019) Factors other than hTau overexpression that contribute to tauopathy-like phenotype in rTg4510 mice. Nat Commun 10:2479
Saito T, Matsuba Y, Mihira N, Takano J, Nilsson P, Itohara S et al (2014) Single App knock-in mouse models of Alzheimer’s disease. Nat Neurosci 17:661–663
Liu ET, Bolcun-Filas E, Grass DS, Lutz C, Murray S, Shultz L et al (2017) Of mice and CRISPR: the post-CRISPR future of the mouse as a model system for the human condition. EMBO Rep 18:187–193
Pickar-Oliver A, Gersbach CA (2019) The next generation of CRISPR-Cas technologies and applications. Nat Rev Mol Cell Biol 20:490–507
Komor AC, Kim YB, Packer MS, Zuris JA, Liu DR (2016) Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533:420–424
Nishida K, Arazoe T, Yachie N, Banno S, Kakimoto M, Tabata M et al (2016) Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems. Science 353:aaf8729
Sasaguri H, Nagata K, Sekiguchi M, Fujioka R, Matsuba Y, Hashimoto S et al (2018) Introduction of pathogenic mutations into the mouse Psen1 gene by Base Editor and Target-AID. Nat Commun 9:2892
Anzalone AV, Koblan LW, Liu DR (2020) Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors. Nat Biotechnol 38:824–844
Zhao D, Li J, Li S, Xin X, Hu M, Price MA et al (2021) Glycosylase base editors enable C-to-A and C-to-G base changes. Nat Biotechnol 39:35–40
Takemoto T (2020) Zygote electroporation for CRISPR/Cas9 delivery to generate genetically modified mice. Methods Mol Biol 2050:121–126
Zuo E, Sun Y, Wei W, Yuan T, Ying W, Sun H et al (2019) Cytosine base editor generates substantial off-target single-nucleotide variants in mouse embryos. Science 364:289–292
Acknowledgments
I thank Professor Toru Takeo (CARD, Kumamoto University) for providing valuable protocols of mouse embryo manipulations. This work was supported by AMED under Grant Number JP15dm0207001 (Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS)) and JSPS KAKENHI Grant Number JP18K07402.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Sasaguri, H. (2023). Introduction of Genetic Mutations Into Mice by Base Editor and Target-AID. In: Hatada, I. (eds) Genome Editing in Animals. Methods in Molecular Biology, vol 2637. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3016-7_9
Download citation
DOI: https://doi.org/10.1007/978-1-0716-3016-7_9
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-3015-0
Online ISBN: 978-1-0716-3016-7
eBook Packages: Springer Protocols